Genomic Health And Biocartis Expand Collaboration To Urology With The Development Of An Idylla Oncotype DX Genomic Prostate Score Test; Co. Will Make €2.5M Payment To Biocartis And Will Make Royalty Payments Based On Net Sales
Benzinga Newsdesk